Chemical firms plan health risk study

European chemical companies are to spend $25m (£15.5m) over the next three years as part of world-wide long-range research into the interaction between chemicals, human health and the environment. Subjects to be studied are endocrine disruption, exposure assessment, risk assessment, chemical carcinogenesis, respiratory toxicity, immunotoxicity and allergy. The project is part of the chemical industry’s […]

European chemical companies are to spend $25m (£15.5m) over the next three years as part of world-wide long-range research into the interaction between chemicals, human health and the environment.

Subjects to be studied are endocrine disruption, exposure assessment, risk assessment, chemical carcinogenesis, respiratory toxicity, immunotoxicity and allergy.

The project is part of the chemical industry’s health, safety and environment programme, Responsible Care. The results will be peer-reviewed and made public, the industry has promised.

The project is being run by the International Council of Chemical Associations, which includes the European Chemical Industry Council, the US Chemical Manufacturers Association and the Japanese Chemical Industry Association.